Recent COVID-19 and mortality after myocardial infarction: a Danish nationwide cohort study

Katrine D Brodersen1,2, Sinna P Ulrichsen1,2, Signe Sørup1,2

  • 1Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus N, Denmark.

Insights

Recent coronavirus disease 2019 (COVID-19) infection increases short-term mortality risk for patients experiencing myocardial infarction (MI), particularly those unvaccinated. Vaccination may mitigate this risk.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Myocardial infarction (MI) is a known complication of coronavirus disease 2019 (COVID-19).
  • Outcomes for MI patients with recent COVID-19 infection are not well-established.
  • The impact of COVID-19 vaccination on MI prognosis requires further investigation.

Purpose of the Study:

  • To investigate the association between recent COVID-19 and mortality following a first-time myocardial infarction.
  • To evaluate the prognostic significance of COVID-19 vaccination status in MI patients with recent COVID-19 infection.

Main Methods:

  • Nationwide, population-based cohort study using linked Danish registries (May 2020 - March 2022).
  • Included adults admitted with a first-time MI.
  • Exposure: Recent COVID-19 (positive PCR test within 90 days before to day of MI).
  • Outcomes: All-cause mortality at 30 and 180 days post-MI.
  • Statistical analysis: Cox proportional-hazards regression with inverse probability weighting, stratified by vaccination status.

Main Results:

  • 12,054 MI patients included; 337 had recent COVID-19.
  • Recent COVID-19 was associated with increased 30-day mortality (adjusted HR 1.64) and 180-day mortality (adjusted HR 1.28).
  • The increased mortality risk was significantly higher in unvaccinated MI patients (30-day HR 2.88; 180-day HR 2.09) compared to vaccinated patients.

Conclusions:

  • Recent COVID-19 infection is linked to elevated short-term mortality after myocardial infarction.
  • The prognostic impact of recent COVID-19 on MI mortality is substantially greater in unvaccinated individuals.
  • COVID-19 vaccination appears to attenuate the adverse effects of recent infection on MI outcomes.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
28
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
20
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
31
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332